Mega Lifesciences PCL (BKK:MEGA)

Mega Lifesciences PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	14,819	15,344	15,681	15,686	14,136	12,589
Other Revenue	39.58	41.09	34.41	40.64	36.67	23.61
Revenue	14,859	15,385	15,716	15,727	14,172	12,613
Revenue Growth (YoY)	-5.47%	-2.10%	-0.07%	10.97%	12.36%	12.98%
Cost of Revenue	7,140	7,590	8,586	8,647	8,225	7,603
Gross Profit	7,719	7,796	7,130	7,080	5,947	5,010
Selling, General & Admin	4,382	4,385	4,191	4,359	3,769	3,288
Operating Expenses	4,382	4,385	4,191	4,359	3,769	3,288
Operating Income	3,337	3,411	2,939	2,722	2,178	1,722
Interest Expense	-42.37	-38.49	-31.25	-28.73	-28.28	-72.28
Interest & Investment Income	64.46	61.74	60.69	39.82	10.03	11.94
Earnings From Equity Investments	-0.32	0.15	0.07	0.18	-1.51	-45.52
Currency Exchange Gain (Loss)	-1,022	-1,082	-706.57	-138.16	118.52	18.11
EBT Excluding Unusual Items	2,337	2,352	2,262	2,595	2,277	1,634
Merger & Restructuring Charges	-	-	-	-	-	-11.7
Pretax Income	2,337	2,352	2,262	2,595	2,277	1,623
Income Tax Expense	351.84	339.63	269.06	354.63	336.02	234.33
Earnings From Continuing Operations	1,985	2,013	1,993	2,240	1,941	1,388
Minority Interest in Earnings	-0.13	-0.07	0.05	1.49	5.97	4.2
Net Income	1,985	2,012	1,993	2,242	1,947	1,393
Net Income to Common	1,985	2,012	1,993	2,242	1,947	1,393
Net Income Growth	-1.62%	0.99%	-11.10%	15.14%	39.79%	22.32%
Shares Outstanding (Basic)	872	872	872	872	872	872
Shares Outstanding (Diluted)	872	872	872	872	872	872
Shares Change (YoY)	-	-	-	-	-	0.12%
EPS (Basic)	2.28	2.31	2.29	2.57	2.23	1.60
EPS (Diluted)	2.28	2.31	2.29	2.57	2.23	1.60
EPS Growth	-1.62%	0.99%	-11.10%	15.14%	39.79%	22.18%
Free Cash Flow	1,769	2,154	1,652	1,692	2,575	1,395
Free Cash Flow Per Share	2.03	2.47	1.90	1.94	2.95	1.60
Dividend Per Share	1.600	1.600	1.600	1.600	1.380	0.900
Dividend Growth	-	-	-	15.94%	53.33%	25.00%
Gross Margin	51.95%	50.67%	45.37%	45.02%	41.97%	39.72%
Operating Margin	22.46%	22.17%	18.70%	17.30%	15.37%	13.65%
Profit Margin	13.36%	13.08%	12.68%	14.25%	13.74%	11.04%
Free Cash Flow Margin	11.90%	14.00%	10.51%	10.76%	18.17%	11.06%
EBITDA	3,521	3,614	3,146	2,917	2,378	1,909
EBITDA Margin	23.70%	23.49%	20.02%	18.55%	16.78%	15.14%
D&A For EBITDA	183.97	202.84	207.49	195.24	200.2	187.09
EBIT	3,337	3,411	2,939	2,722	2,178	1,722
EBIT Margin	22.46%	22.17%	18.70%	17.30%	15.37%	13.65%
Effective Tax Rate	15.06%	14.44%	11.90%	13.67%	14.76%	14.44%
Revenue as Reported	14,923	15,447	15,776	15,767	14,301	12,643
Advertising Expenses	-	1,232	1,323	1,266	1,052	930.15

Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.